pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
ERAS-4001
Solid Tumor
$ERAS
Erasca, Inc.
Phase 2
ERC-1671
Gliovac
Gliosarcoma
ERC Belgium SA
ERGOCALCIFEROL CAPSULES,
ERGOCALCIFEROL CAPSULES,
no indication
PURACAP PHARM LLC
ERGOMAR SUBLINGUAL
ERGOMAR SUBLINGUAL (ERGOTAMINE TARTRATE)
← prev
page 82 of 231
next →
131
Pain
89
Neurology
1
no indication
PANGEA
ERLOTINIB
ERLOTINIB
no indication
EUGIA PHARMA
Preclinical
ERNA-101
Ovarian Cancer
$ERNA
Ernexa Therapeutics Inc.
Phase 1
ERSM-5404
Colorectal Cancer
Hibercell Inc
ERTAPENEM
ERTAPENEM
no indication
EUGIA PHARMA
ERY
ERY (ERYTHROMYCIN)
no indication
PADAGIS US
ERYTHROMYCIN ETHYLSUCCINATE
ERYTHROMYCIN ETHYLSUCCINATE
no indication
CADILA PHARMS LTD
ERYTHROMYCIN LACTOBIONATE
ERYTHROMYCIN LACTOBIONATE
no indication
GLAND
ESCITALOPRAM
ESCITALOPRAM
no indication
ALMATICA
ESMOLOL HYDROCHLORIDE IN SODIUM CHLORIDE
ESMOLOL HYDROCHLORIDE IN SODIUM CHLORIDE
no indication
MYLAN LABS LTD
ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES, 20 MG
ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES, 20 MG
no indication
MARKSANS PHARMA
ESOMEPRAZOLE STRONTIUM
ESOMEPRAZOLE STRONTIUM
no indication
BELCHER
Preclinical
ESP-2001
Primary Sclerosing Cholangitis
$ESPR
Esperion Therapeutics, Inc.
Preclinical
ET-101
Amyotrophic Lateral Sclerosis
Eikonoklastes Therapeutics Inc
Phase 2
ET-1402
Hepatocellular Carcinoma
Eureka Therapeutics Inc
Phase 2
ETD-001
Cystic Fibrosis
Enterprise Therapeutics Ltd
Preclinical
ETH-42
Primary Ciliary Dyskinesia
ethris GmbH
ETONOGESTREL AND ETHINYL ESTRADIOL VAGINAL RING
ETONOGESTREL AND ETHINYL ESTRADIOL VAGINAL RING
no indication
XIROMED
Phase 2
ETX-101
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy)
Encoded Therapeutics Inc
Phase 2
ETX-19477
Ovarian Cancer
858 Therapeutics Inc
Phase 2
ETX-636
Human Epidermal Growth Factor Receptor 2 Negative Breast…
ENSEM Therapeutics Inc
Phase 2
EU-101
Colorectal Cancer
Eutilex Co Ltd
Phase 1
EV68-228-N
Flaccid Paralysis
KBio Inc
Phase 2
EVM-14
Esophageal Squamous Cell Carcinoma (ESCC)
Everest Medicines Ltd
Phase 2
EVO-756
Chronic Inducible Urticaria
$EVMN
Evommune, Inc.
Phase 1
EVOLVE-104
Anal Cancer
EvolveImmune Therapeutics Inc
Preclinical
EVQ-218
Aspergillosis
Evoq Nano Inc
